Rx (Prescription Medicine)
USD $ 120.00
Emgrast 300mcg 注射液是一种关键药物，用于刺激体内白细胞（特别是中性粒细胞）的生成。其活性成分为 Filgrastim，是一种重组人源性中性粒细胞集落刺激因子（G-CSF）。Filgrastim 通过向骨髓发出信号，促使其增加中性粒细胞的生成并将其释放至血液循环。在接受化疗的患者中，化疗常会抑制免疫系统，导致中性粒细胞计数（中性粒细胞减少症）显著下降。通过提升中性粒细胞水平，Emgrast 有助于降低这些高危人群的感染风险。
Emgrast 300mcg 注射液的适应症包括：预防和治疗接受抑制骨髓抑制化疗的各种癌症患者的中性粒细胞减少症；骨髓移植患者；以及动员外周血造血干细胞用于自体移植。剂量和治疗时长取决于患者的病情、对疗法的反应以及具体的治疗方案。通常通过皮下或静脉给药。常见不良反应可能包括骨痛、发热、头痛和疲劳。必须将 Emgrast 300mcg 注射液储存在受控室温环境下，避光保存，且不可冷冻。务必遵循医护人员关于给药和储存的指示。
| Medicine Form | |
|---|---|
| Rx Status | |
| Medicine Type | |
| Molecule | |
| Strength |
其他品牌的 FILGRASTIM 300 Mcg — 同一活性成分且强度相同，但来自不同制造商。
医学审核
Renu Meena, B.Pharm
Medical Content Writer
Renu Meena is an experienced Medical Content Writer with a strong foundation in pharmacy practice. She holds a Bachelor of Pharmacy (B.Pharm) degree from Rajasthan University of Health Sciences (RUHS), Jaipur, and is registered with the Rajasthan State Pharmacy Council (Reg. No. 55661). With 4+ years of experience across clinical pharmacy and medical content development, she creates evidence-based content for medicines, diseases, and patient education. Her work is shaped by a strong understanding of pharmacovigilance and regulatory standards, including ICH guidelines, GVP modules, ICD-10/11, and safety reporting requirements. Renu focuses on making complex medical information simple, accurate, and useful for readers while maintaining high quality and compliance.
